Research Article
Longitudinal Relationship between the Introduction of Medicinal Cannabis and Polypharmacy: An Australian Real-World Evidence Study
Table 1
Spectrum therapeutics product avalibility in Australia.
| | Spectrum products | Product profile (THC:CBD ratio) | Percentage of THC & CBD per Gram of weight dried flower (%) | Milligram of THC & CBD per millilitre of oil (mg/mL) | Milligram of THC & CBD per softgel (mg) |
| | Red | THC-dominant (2 : 1) | 16 THC: <1 CBD | 26.3 THC: <1 CBD | 2.5 or 10 THC: <1 CBD | | Blue | Balanced (1 : 1) | NA | 10 THC: 12–15 CBD | 2.5 THC: 3.75 CBD | | Yellow | CBD-dominant (1 : 2) | NA | <1 THC: 20 CBD | <1 THC: 20 CBD |
|
|
